Search and Discover China Trade Knowledge from Trusted Sources™
Current Language: English
Login
Register
Forgot password?
Home
Start Here
Discover
Popular Search Results
Knowledge Center
Trusted Sources™
Trade Intelligence
Stay Informed
Trade
Directory
Coming Soon
Information
Market
Coming Soon
Sitemap
navigate
About Us
Company
Contact / Blog
Subscribe
Email / RSS
User Center
Search this Author
GSK lead right to the use of T...
According to a new survey released by GlaxoSmithKline (GSK) in 2010, ranking medical use rights index (the Access to Medicines Index 2010) ranked first, ahead of MSD, Novartis, Sanofi - Aventis ...
GSK Research Center, multinati...
Following a 25% reduction in disease AstraZeneca R & D, the drug maker GlaxoSmithKline (G SK) said it has its research center in Italy sold to drug development service provider A ptuit Inc. Finan...
WuXi PharmaTech merger or brea...
Was considered to be domestic pharmaceutical industry R & D Outsourcing (CRO) industry "leader" of the existing agreement between the U.S. company's acquisition of drug research and development, ...
Atrial fibrillation drugs with...
According to Decision Resources Inc. (Decision Resources), a report on its view that the market as new drugs and use of the market size of atrial fibrillation in 10 years will reach nearly 70 bill...
Novartis kidney cancer drug fa...
Novartis kidney cancer treatment drug Afinitor (by Weimo Division) rejected into the UK national health service system, mainly because of their drug prices are too expensive. National Institutes...
Japan to develop new technolog...
Japanese researchers recently reported that they developed a new technology, only to analyze human saliva, can be oral cancer screening, breast and pancreatic cancer and other cancers, and high accu...
Invested billions of euros to ...
European Commission unveiled a 64 billion euros in R & D and Innovation Fund, focusing on areas of research focus on medical and health of SMEs. The funds allocated in 2009 an increase of 30%, in ...
The world's first oral treatme...
My eye specialist in the field of treating amblyopia has been constantly exploring family of Professor Xia Yunfu eye after 60 years of clinical practice, successfully developed the first oral treatm...
Vietnam Chemical mechanical eq...
According to Vietnamese media has reported, with the economic recovery, Vietnam's rubber, plastic, starch and other industries show strong momentum, while the accompanying chemical machinery equipm...
Observation: the world pharmac...
In recent years, both from the number of new drugs or from the quality point of view, the global pharmaceutical research and development (R & D) productivity decline has been well known. This mak...
Italy plans to generic drug pr...
Beginning next year, the Italian Health Service (SSN) will be adjusted according to the European average price of generic drugs in the maximum reimbursement rate, the government said this move cou...
Weight loss drug Qnexa five se...
Over the past 10 years, pharmaceutical companies have been fierce competition, looking forward to the first one to market prescription drugs for the treatment of weight loss, but failed to succeed. ...
FDA: The first generic version...
July 23, the U.S. Food and Drug Administration FDA approved Sandoz, Lovenox enoxaparin sodium injection generic drug listing applications. This is the first enoxaparin sodium generic drugs, the dru...
Global pharmaceutical industry...
In recent years, both from the number of new drugs or from the quality point of view, the global pharmaceutical research and development (R & D) productivity decline has been well known. This mak...
European CEP certification rel...
Q: long-term stability test of a product only had 25 ℃ ± 2 ℃, I ask how to determine the storage temperature? A: EU has clearly defined, if you want to apply for retesting period, you only pr...
Japan's Eisai to the FDA for a...
FDA has accepted Japan's Eisai Corporation of Oral Suspension (40 mg / ml) Banzel new drug application for the drug for the treatment of epilepsy. Eisai said that this preparation can be used fo...
Archives
2013
2011
January 2011
February 2011
March 2011
April 2011
May 2011
June 2011
August 2011
2010
January 2010
February 2010
March 2010
April 2010
May 2010
June 2010
July 2010
August 2010
September 2010
October 2010
November 2010
December 2010
2009
January 2009
February 2009
March 2009
April 2009
May 2009
June 2009
July 2009
August 2009
September 2009
October 2009
November 2009
December 2009
2008
January 2008
February 2008
March 2008
April 2008
May 2008
June 2008
July 2008
August 2008
September 2008
October 2008
November 2008
December 2008
2007
January 2007
February 2007
March 2007
April 2007
May 2007
June 2007
July 2007
August 2007
September 2007
October 2007
November 2007
December 2007
2006
April 2006
May 2006
June 2006
July 2006
August 2006
September 2006
October 2006
November 2006
December 2006
Main
sourcejuice
Pharmaceutical Min...
Pharmaceutical M...
Pharmaceutical M...
Privacy Policy
|
Legal
|
Advertising
|
Help
|
Contact us
|
My SourceJuice
Designated brands and trademarks are property of their respective owners. Use of this website constitutes acceptance of SourceJuice.com
Legal
and
Privacy Policy
.
Copyright © 2007 - 2009 SourceJuice.com & SourceJuice All Rights Reserved.